ACE-011 With Lenalidomide+Dexamethasone for Relapsed/Refractory Multiple Myeloma

This study is currently recruiting participants.
Verified March 2013 by Massachusetts General Hospital
Sponsor:
Information provided by (Responsible Party):
Anuj K. Mahindra, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01562405
First received: January 8, 2012
Last updated: March 19, 2013
Last verified: March 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2014
  Estimated Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)